|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - LIGAND PHARMACEUTICALS INC (LGND)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-03-13 Purchase |
2019-03-15 1:59 pm |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
202 | $112.5 | $22,727 | 59,118 (Direct Indirect) |
View |
| 2019-03-13 Purchase |
2019-03-15 1:58 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
2,500 | $114.3 | $285,725 | 141,399 (Direct) |
View |
| 2018-10-08 Sale |
2018-10-09 4:24 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,500 | $254 | $634,978 | 42,556 (Direct) |
View |
| 2018-10-01 Sale |
2018-10-02 6:24 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,500 | $275 | $687,610 | 26,142 (Direct) |
View |
| 2018-10-01 Sale |
2018-10-02 6:24 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
12,000 | $273.9 | $3,286,560 | 117,388 (Direct) |
View |
| 2017-07-13 Sale |
2018-09-27 9:25 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
262,881 | $19.15 | $5,034,250 | 6,038,083 (Direct) |
View |
| 2018-09-17 Sale |
2018-09-18 6:16 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,813 | $250.7 | $705,181 | 30,576 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-06 10:40 am |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
5,000 | $255.1 | $1,275,250 | 31,856 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-05 8:18 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
12,000 | $255 | $3,060,082 | 115,300 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-05 8:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
19,417 | $255 | $4,951,065 | 47,180 (Direct) |
View |
| 2018-09-04 Sale |
2018-09-05 7:59 pm |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
3,335 | $255 | $850,292 | 24,784 (Direct) |
View |
| 2018-08-30 Sale |
2018-08-31 1:22 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
3,500 | $258.2 | $903,875 | 85,419 (Direct) |
View |
| 2018-08-29 Sale |
2018-08-29 8:35 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
18,357 | $256.7 | $4,712,060 | 25,099 (Direct) |
View |
| 2018-08-16 Sale |
2018-08-17 7:38 pm |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
27,942 | $241.9 | $6,760,159 | 78,254 (Direct Indirect) |
View |
| 2018-08-16 Sale |
2018-08-17 7:38 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
9,000 | $239.8 | $2,158,002 | 48,223 (Direct) |
View |
| 2018-08-16 Sale |
2018-08-17 7:37 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
34,500 | $242 | $8,347,560 | 171,993 (Direct) |
View |
| 2018-08-16 Sale |
2018-08-17 7:37 pm |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
42,287 | $240 | $10,150,808 | 66,811 (Direct) |
View |
| 2018-07-02 Sale |
2018-07-03 6:50 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,500 | $207.5 | $518,699 | 28,642 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-03-14 Exercise |
2019-03-15 2:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
14,894 | $9.97 | 140,447 (Direct) |
View |
| 2019-03-14 Exercise |
2019-03-15 2:00 pm |
N/A 2021-04-18 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
14,894 | $9.97 | 140,447 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
6,404 | $0 | 29,298 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:35 pm |
N/A 2029-03-02 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
29,298 | $118 | 29,298 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
7,472 | $0 | 125,553 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:35 pm |
N/A 2029-03-02 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
34,181 | $118 | 125,553 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
12,809 | $0 | 138,899 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:35 pm |
N/A 2029-03-02 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
58,596 | $118 | 138,899 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:34 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
3,202 | $0 | 45,897 (Direct) |
View |
| 2019-02-11 Option Award |
2019-02-13 4:34 pm |
N/A 2029-03-02 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
14,649 | $118 | 45,897 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:32 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
1,370 | $0 | 42,695 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:32 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
1,412 | $0 | 42,695 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
3,547 | $0 | 119,365 (Direct) |
View |
| 2019-01-23 Tax Withholding |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
1,284 | $111.8 | 119,365 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
3,715 | $0 | 119,365 (Direct) |
View |
| 2019-01-23 Tax Withholding |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
1,284 | $111.8 | 119,365 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
7,256 | $0 | 129,258 (Direct) |
View |
| 2019-01-23 Tax Withholding |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
3,597 | $111.8 | 129,258 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
6,390 | $0 | 129,258 (Direct) |
View |
| 2019-01-23 Tax Withholding |
2019-01-25 4:31 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
3,168 | $111.8 | 129,258 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:30 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
2,418 | $0 | 10,677 (Direct) |
View |
| 2019-01-23 Tax Withholding |
2019-01-25 4:30 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
713 | $111.8 | 10,677 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 4:30 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
2,230 | $0 | 10,677 (Direct) |
View |
| 2019-01-23 Tax Withholding |
2019-01-25 4:30 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
612 | $111.8 | 10,677 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:17 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
244 | $21.92 | 39,913 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:17 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
1,931 | $74.42 | 39,913 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:17 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
675 | $56.26 | 39,913 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:17 am |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
244 | $21.92 | 39,913 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:17 am |
N/A 2025-02-10 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
675 | $56.26 | 39,913 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:17 am |
N/A 2024-02-12 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
1,931 | $74.42 | 39,913 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:16 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
4,000 | $16.14 | 119,209 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:16 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
29,790 | $16.14 | 119,209 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:16 am |
N/A 2019-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
29,790 | $16.14 | 119,209 (Direct) |
View |
| 2019-01-10 Exercise |
2019-01-14 09:16 am |
N/A 2019-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
4,000 | $16.14 | 119,209 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-17 7:58 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
3,400 | $21.92 | 37,063 (Direct) |
View |
| 2018-12-17 Exercise |
2018-12-17 7:58 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
3,400 | $21.92 | 37,063 (Direct) |
View |
| 2018-12-12 Exercise |
2018-12-12 5:32 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
7,999 | $9.97 | 113,387 (Direct) |
View |
| 2018-12-12 Exercise |
2018-12-12 5:32 pm |
N/A 2021-04-18 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
7,999 | $9.97 | 113,387 (Direct) |
View |
| 2018-10-24 Exercise |
2018-10-25 5:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,688 | $14.47 | 33,663 (Direct) |
View |
| 2018-10-24 Exercise |
2018-10-25 5:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
1,212 | $21.92 | 33,663 (Direct) |
View |
| 2018-10-24 Exercise |
2018-10-25 5:44 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
1,212 | $21.92 | 33,663 (Direct) |
View |
| 2018-10-24 Exercise |
2018-10-25 5:44 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,688 | $14.47 | 33,663 (Direct) |
View |
| 2018-10-12 Exercise |
2018-10-15 12:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,754 | $89.75 | 47,639 (Direct) |
View |
| 2018-10-12 Exercise |
2018-10-15 12:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,329 | $119.3 | 47,639 (Direct) |
View |
| 2018-10-12 Exercise |
2018-10-15 12:55 pm |
N/A 2025-04-24 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,754 | $89.75 | 47,639 (Direct) |
View |
| 2018-10-12 Exercise |
2018-10-15 12:55 pm |
N/A 2026-05-23 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,329 | $119.3 | 47,639 (Direct) |
View |
| 2018-10-11 Exercise |
2018-10-12 6:52 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,000 | $14.47 | 29,763 (Direct) |
View |
| 2018-10-11 Exercise |
2018-10-12 6:52 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,000 | $14.47 | 29,763 (Direct) |
View |
| 2018-10-01 Exercise |
2018-10-02 6:24 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
2,088 | $9.97 | 117,388 (Direct) |
View |
| 2018-10-01 Exercise |
2018-10-02 6:24 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
12,000 | $14.47 | 117,388 (Direct) |
View |
| 2018-10-01 Exercise |
2018-10-02 6:24 pm |
N/A 2021-04-18 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
2,088 | $9.97 | 117,388 (Direct) |
View |
| 2018-10-01 Exercise |
2018-10-02 6:24 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
12,000 | $14.47 | 117,388 (Direct) |
View |
| 2017-07-13 Other |
2018-09-27 9:25 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
38,630 | $38,630 | 6,038,083 (Direct) |
View |
| 2017-07-13 Other |
2018-09-27 9:25 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
1,916,509 | $1,916,509 | 6,038,083 (Direct) |
View |
| 2018-09-17 Exercise |
2018-09-18 6:16 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,813 | $100.4 | 30,576 (Direct) |
View |
| 2018-09-17 Exercise |
2018-09-18 6:16 pm |
N/A 2027-02-24 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
2,813 | $100.4 | 30,576 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-06 10:40 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,500 | $8.58 | 31,856 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-06 10:40 am |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,500 | $17.88 | 31,856 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-06 10:40 am |
N/A 2020-05-25 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,500 | $8.58 | 31,856 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-06 10:40 am |
N/A 2019-05-29 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
2,500 | $17.88 | 31,856 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:18 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
1,044 | $9.97 | 115,300 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:18 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
12,000 | $14.47 | 115,300 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:18 pm |
N/A 2021-04-18 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
1,044 | $9.97 | 115,300 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:18 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO |
12,000 | $14.47 | 115,300 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
469 | $21.92 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
5,985 | $74.42 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
7,077 | $56.26 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
5,886 | $85.79 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A 2025-02-10 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
7,077 | $56.26 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A 2024-02-12 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
5,985 | $74.42 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A 2026-02-11 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
5,886 | $85.79 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 8:00 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP |
469 | $21.92 | 47,180 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 7:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
3,335 | $12.53 | 24,784 (Direct) |
View |
| 2018-09-04 Exercise |
2018-09-05 7:59 pm |
N/A 2022-05-31 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
3,335 | $12.53 | 24,784 (Direct) |
View |
| 2018-08-29 Exercise |
2018-08-29 8:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
11,540 | $85.79 | 25,099 (Direct) |
View |
| 2018-08-29 Exercise |
2018-08-29 8:35 pm |
N/A 2026-02-11 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
11,540 | $85.79 | 25,099 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
3,007 | $14.47 | 171,993 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
12,993 | $14.47 | 171,993 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
3,007 | $14.47 | 171,993 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO |
12,993 | $14.47 | 171,993 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
5,000 | $9.6 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
7,335 | $10.12 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
7,335 | $12.53 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
7,335 | $32.3 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A 2020-10-07 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
5,000 | $9.6 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A 2021-06-01 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
7,335 | $10.12 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A 2022-05-31 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
7,335 | $12.53 | 66,811 (Direct) |
View |
| 2018-08-16 Exercise |
2018-08-17 7:37 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
7,335 | $32.3 | 66,811 (Direct) |
View |
| 2018-08-06 Tax Withholding |
2018-08-07 4:35 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO |
836 | $226.7 | 13,559 (Direct) |
View |
| 2018-06-19 Option Award |
2018-07-03 6:47 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
2,474 | $195.9 | 2,474 (Direct) |
View |
| 2018-06-19 Option Award |
2018-07-03 6:45 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,474 | $195.9 | 2,474 (Direct) |
View |
| 2018-06-19 Option Award |
2018-07-03 6:43 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
2,474 | $195.9 | 2,474 (Direct) |
View |
| 2018-06-19 Option Award |
2018-07-03 6:42 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,474 | $195.9 | 2,474 (Direct) |
View |
| 2018-06-19 Option Award |
2018-07-03 6:39 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
2,474 | $195.9 | 2,474 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 20 Mar 2019 18:51:44 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |